According to a new report Europe Life Science Analytics Market, published by KBV research, the Europe Life Science Analytics Market would witness market growth of 7.1% CAGR during the forecast period (2020-2026).
The Germany market dominated the Europe Pharmacovigilance Market by Country 2019, growing at a CAGR of 6.5 % during the forecast period. The UK market is experiencing a CAGR of 6.8% during (2020 - 2026). Additionally, The France market is anticipated to witness a CAGR of 8.4% during (2020 - 2026).
The Pharmaceutical market dominated the Russia Life Science Analytics Market by End User 2019, growing at a CAGR of 5.9 % during the forecast period. The Medical Devices market is estimated to grow at a CAGR of 6.4% during (2020 - 2026). Additionally, The Other End Users market is expected to witness highest CAGR of 9.9% during (2020 - 2026).
The On-Premise market dominated the Italy Life Science Analytics Market by Delivery Mode 2019, thereby, achieving a market value of $89.7 million by 2026. The On-demand market would showcase a CAGR of 10.2% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/europe-life-science-analytics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Oracle Corporation, IBM Corporation, Microsoft Corporation, Accenture PLC, Cognizant Technology Solutions Corporation, Infosys Limited, IQVIA Holdings, Inc., AllScripts Healthcare Solutions, Inc., Cerner Corporation and SAS Institute, Inc.
By Component
By Application
By End User
By Delivery Mode
By Type
By Country
Companies Profiled
Unique Offerings from KBV Research